r&d systems 产品目录--泽浩公司 |
r&d systems 产品目录列表 page 5 >> 1 2 3 4 5 6 7 8 9 10 >>..more |
产品编号 |
产品描述 |
规格/包装 |
品牌 |
413-ml-025 |
recombinant mouse il-13 (25 ug) |
25 ug |
r&d systems |
413-ml-025/cf |
recombinant mouse il-13, cf (25 ug) |
25 ug |
r&d systems |
4140-me-050 |
recombinant canine hgf r/c-met/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
414-cs-005 |
recombinant mouse g-csf (5 ug) |
5 ug |
r&d systems |
414-cs-005/cf |
recombinant mouse g-csf, cf (5 ug) |
5 ug |
r&d systems |
414-cs-025 |
recombinant mouse g-csf (25 ug) |
25 ug |
r&d systems |
414-cs-025/cf |
recombinant mouse g-csf, cf (25 ug) |
25 ug |
r&d systems |
4150-pp-050 |
recombinant human active pp2c alpha/ppm1a, cf (50 ug) |
50 ug |
r&d systems |
415-ml-010 |
recombinant mouse gm-csf (10 ug) |
10 ug |
r&d systems |
415-ml-010/cf |
recombinant mouse gm-csf, cf (10 ug) |
10 ug |
r&d systems |
415-ml-050 |
recombinant mouse gm-csf (50 ug) |
50 ug |
r&d systems |
415-ml-050/cf |
recombinant mouse gm-csf, cf (50 ug) |
50 ug |
r&d systems |
416-ml-010/cf |
recombinant mouse m-csf, cf (10 ug) |
10 ug |
r&d systems |
416-ml-050/cf |
recombinant mouse m-csf, cf (50 ug) |
50 ug |
r&d systems |
417-ml-005 |
recombinant mouse il-10 (5 ug) |
5 ug |
r&d systems |
417-ml-005/cf |
recombinant mouse il-10, cf (5 ug) |
5 ug |
r&d systems |
417-ml-025 |
recombinant mouse il-10 (25 ug) |
25 ug |
r&d systems |
417-ml-025/cf |
recombinant mouse il-10, cf (25 ug) |
25 ug |
r&d systems |
418-ml-005 |
recombinant mouse il-11 (5 ug) |
5 ug |
r&d systems |
418-ml-005/cf |
recombinant mouse il-11, cf (5 ug) |
5 ug |
r&d systems |
418-ml-025 |
recombinant mouse il-11 (25 ug) |
25 ug |
r&d systems |
418-ml-025/cf |
recombinant mouse il-11, cf (25 ug) |
25 ug |
r&d systems |
419-ml-010 |
recombinant mouse il-12 (10 ug) |
10 ug |
r&d systems |
419-ml-010/cf |
recombinant mouse il-12, cf (10 ug) |
10 ug |
r&d systems |
419-ml-050 |
recombinant mouse il-12 (50 ug) |
50 ug |
r&d systems |
419-ml-050/cf |
recombinant mouse il-12, cf (50 ug) |
50 ug |
r&d systems |
4206-b7-100 |
recombinant mouse b7-h4/fc chimera, cf |
100 µg |
r&d systems |
4207-dm-025 |
recombinant human dmc/vcc-1 |
25 µg |
r&d systems |
4207-dm-025 |
recombinant human dmc/vcc-1 (25 ug) |
25 ug |
r&d systems |
4207-dm-025/cf |
recombinant human dmc/vcc-1, cf |
25 µg |
r&d systems |
4207-dm-025/cf |
recombinant human dmc/vcc-1, cf (25 ug) |
25 ug |
r&d systems |
4208-nx-050 |
recombinant rat neurexophilin 1/nxph1, cf |
50 µg |
r&d systems |
4208-nx-050 |
recombinant rat neurexophilin 1/nxph1, cf (50 ug) |
50 ug |
r&d systems |
4209-fc-050 |
recombinant human ficolin-1, cf |
50 µg |
r&d systems |
420-me-020 |
recombinant mouse ccl11/eotaxin (20 ug) |
20 ug |
r&d systems |
420-me-020/cf |
recombinant mouse ccl11/eotaxin, cf (20 ug) |
20 ug |
r&d systems |
420-me-100 |
recombinant mouse ccl11/eotaxin (100 ug) |
100 ug |
r&d systems |
420-me-100/cf |
recombinant mouse ccl11/eotaxin, cf (100 ug) |
100 ug |
r&d systems |
4218-ut-050 |
recombinant human uteroglobin, cf |
50 µg |
r&d systems |
421-ml-025 |
recombinant mouse il-17 (25 ug) |
25 ug |
r&d systems |
421-ml-025/cf |
recombinant mouse il-17, cf (25 ug) |
25 ug |
r&d systems |
4234-zn-010 |
recombinant human psma/folh1, cf |
10 µg |
r&d systems |
4234-zn-010 |
recombinant human psma/folh1, cf (10 ug) |
10 ug |
r&d systems |
4237-sr-050 |
recombinant mouse sorcs2, cf |
50 µg |
r&d systems |
423-f8-025 |
recombinant mouse fgf-8b (25 ug) |
25 ug |
r&d systems |
423-f8-025/cf |
recombinant mouse fgf-8b, cf (25 ug) |
25 ug |
r&d systems |
4245-ad-020 |
recombinant human adamts13, cf |
20 µg |
r&d systems |
424-fc-025 |
recombinant mouse fgf-8c (25 ug) |
25 ug |
r&d systems |
424-fc-025/cf |
recombinant mouse fgf-8c, cf (25 ug) |
25 ug |
r&d systems |
425-r1-050 |
recombinant mouse stnf ri/tnfrsf1a (50 ug) |
50 ug |
r&d systems |
425-r1-050/cf |
recombinant mouse soluble tnf ri/tnfrsf1a, cf (50 ug) |
50 ug |
r&d systems |
426-r2-050 |
recombinant mouse stnf rii/tnfrsf1b (50 ug) |
50 ug |
r&d systems |
426-r2-050/cf |
recombinant mouse soluble tnf rii/tnfrsf1b, cf (50 ug) |
50 ug |
r&d systems |
4270-dm-025 |
recombinant mouse dmc/vcc-1 |
25 µg |
r&d systems |
4270-dm-025 |
recombinant mouse dmc/vcc-1 |
25 µg |
r&d systems |
4270-dm-025/cf |
recombinant mouse dmc/vcc-1, cf |
25 µg |
r&d systems |
4270-dm-025/cf |
recombinant mouse dmc/vcc-1, cf |
25 µg |
r&d systems |
427-fl-005/cf |
recombinant mouse flt-3 ligand, cf (5 ug) |
5 ug |
r&d systems |
427-fl-025/cf |
recombinant mouse flt-3 ligand, cf (25 ug) |
25 ug |
r&d systems |
4289-eg-025 |
recombinant human pro-egf (25 ug) |
25 ug |
r&d systems |
4289-eg-025 |
recombinant human pro-egf (aa 21-1023) |
25 µg |
r&d systems |
4289-eg-025/cf |
recombinant human pro-egf (aa 21-1023), cf |
25 µg |
r&d systems |
4289-eg-025/cf |
recombinant human pro-egf, cf (25 ug) |
25 ug |
r&d systems |
428-p5-025 |
recombinant mouse ccl12/mcp-5 (25 ug) |
25 ug |
r&d systems |
428-p5-025/cf |
recombinant mouse ccl12/mcp-5, cf (25 ug) |
25 ug |
r&d systems |
4290-s4-050 |
recombinant human igsf4d, cf |
50 µg |
r&d systems |
4294-mr-050 |
recombinant mouse il-22 r, cf |
50 µg |
r&d systems |
4294-mr-050 |
recombinant mouse il-22 r, cf (50 ug) |
50 ug |
r&d systems |
4295-kr-025 |
recombinant rat kremen-2, cf |
25 µg |
r&d systems |
4296-lr-050 |
recombinant human lrpap, cf |
50 µg |
r&d systems |
4296-lr-050 |
recombinant human lrpap, cf (50 ug) |
50 ug |
r&d systems |
4297-mg-050 |
recombinant mouse mgl1, cf |
50 µg |
r&d systems |
4297-mg-050 |
recombinant mouse mgl1, cf (50 ug) |
50 ug |
r&d systems |
4298-np-050 |
recombinant mouse nephronectin, cf |
50 µg |
r&d systems |
429-fr-100 |
recombinant mouse gfr alpha-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
4306-ms-010 |
recombinant human msp (cys 672 ala) |
10 µg |
r&d systems |
4306-ms-010 |
recombinant human msp (cys 672 ala) (10 ug) |
10 ug |
r&d systems |
4306-ms-010/cf |
recombinant human msp (cys 672 ala), cf |
10 µg |
r&d systems |
4306-ms-010/cf |
recombinant human msp (cys 672 ala), cf (10 ug) |
10 ug |
r&d systems |
4307-ad-020 |
recombinant human adamts4, cf |
20 µg |
r&d systems |
4308-se-010 |
recombinant human prolyl oligopeptidase/prep, cf |
10 µg |
r&d systems |
430-ri-050 |
recombinant mouse tnf ri/tnfrsf1a/fc chimera (50 ug) |
50 ug |
r&d systems |
430-ri-050/cf |
recombinant mouse tnf ri/tnfrsf1a/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
4318-pr-050 |
recombinant mouse pilr-alpha, cf |
50 µg |
r&d systems |
431-ms-100 |
recombinant mouse msp r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
4325-fc-050 |
recombinant human fc gamma riiia/cd16a, cf |
50 µg |
r&d systems |
4326-rg-050 |
recombinant rat igf-i, cf |
50 µg |
r&d systems |
4327-sa-050 |
recombinant human s100a13, cf |
50 µg |
r&d systems |
4328-sa-050 |
recombinant mouse s100a13, cf |
50 µg |
r&d systems |
4329-eg-025 |
recombinant mouse egfl6, cf |
25 µg |
r&d systems |
432-b3-200 |
recombinant mouse ephb3/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
433-mc-025 |
recombinant mouse lix (25 ug) |
25 ug |
r&d systems |
433-mc-025/cf |
recombinant mouse lix, cf (25 ug) |
25 ug |
r&d systems |
434-ct-200 |
recombinant mouse ctla-4/fc chimera (200 ug) |
200 ug |
r&d systems |
434-ct-200/cf |
recombinant mouse ctla-4/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
4359-da-050 |
recombinant human histone deacetylase 8, cf |
50 µg |
r&d systems |
435-fa-050 |
recombinant mouse fas/tnfrsf6/fc chimera (50 ug) |
50 ug |
r&d systems |
435-fa-050/cf |
recombinant mouse fas (cd95)/tnfrsf6/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
4376-tg-050 |
recombinant human transglutaminase 2/tgm2, cf |
50 µg |
r&d systems |
437-mr-100 |
recombinant mouse bmpr-ia/alk-3/fc chimera (100 ug) |
100 ug |
r&d systems |
437-mr-100/cf |
recombinant mouse bmpr-ia/alk-3/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
4384-cd-050 |
recombinant human cdo, cf |
50 µg |
r&d systems |
4385-cd-050 |
recombinant human cd109, cf |
50 µg |
r&d systems |
4386-dm-050 |
recombinant mouse dmp-1, cf |
50 µg |
r&d systems |
4387-er-050 |
recombinant mouse erbb4/fc chimera, cf |
50 µg |
r&d systems |
4387-er-050 |
recombinant mouse erbb4/fc chimera, cf |
50 µg |
r&d systems |
4388-mr-050 |
recombinant mouse il-20 r beta/fc chimera, cf |
50 µg |
r&d systems |
4389-or-050 |
recombinant human osm r beta/fc chimera, cf |
50 µg |
r&d systems |
438-ct-010 |
recombinant mouse cardiotrophin-1 (ct-1) (10 ug) |
10 ug |
r&d systems |
438-ct-010/cf |
recombinant mouse cardiotrophin-1 (ct-1), cf (10 ug) |
10 ug |
r&d systems |
438-ct-050 |
recombinant mouse cardiotrophin-1 (ct-1) (50 ug) |
50 ug |
r&d systems |
438-ct-050/cf |
recombinant mouse cardiotrophin-1 (ct-1), cf (50 ug) |
50 ug |
r&d systems |
4394-as-050 |
recombinant human asgpr1, cf |
50 µg |
r&d systems |
4394-as-050 |
recombinant human asgpr1, cf |
50 µg |
r&d systems |
4395-sr-050 |
recombinant mouse sorcs1, cf |
50 µg |
r&d systems |
4395-sr-050 |
recombinant mouse sorcs1, cf (50 ug) |
50 ug |
r&d systems |
4397-en-010 |
recombinant human cd39/entpd1, cf |
10 µg |
r&d systems |
4397-en-010 |
recombinant human cd39/entpd1, cf |
10 µg |
r&d systems |
4398-en-010 |
recombinant mouse cd39/entpd1, cf |
10 µg |
r&d systems |
4398-en-010 |
recombinant mouse cd39/entpd1, cf |
10 µg |
r&d systems |
4399-en-010 |
recombinant human cd39l2/entpd6, cf |
10 µg |
r&d systems |
439-md-025 |
recombinant mouse ccl22/mdc (25 ug) |
25 ug |
r&d systems |
439-md-025/cf |
recombinant mouse ccl22/mdc, cf (25 ug) |
25 ug |
r&d systems |
4400-en-010 |
recombinant human cd39l3/entpd3, cf |
10 µg |
r&d systems |
440-m3-025 |
recombinant mouse ccl19/mip-3 beta (25 ug) |
25 ug |
r&d systems |
440-m3-025/cf |
recombinant mouse ccl19/mip-3 beta, cf (25 ug) |
25 ug |
r&d systems |
4415-su-010 |
recombinant human arylsulfatase b/arsb, cf |
10 µg |
r&d systems |
4416-ad-020 |
recombinant human adam12, cf |
20 µg |
r&d systems |
441-op-050 |
recombinant mouse osteopontin (opn) (50 ug) |
50 ug |
r&d systems |
441-op-050/cf |
recombinant mouse osteopontin (opn), cf (50 ug) |
50 ug |
r&d systems |
441-op-200 |
recombinant mouse osteopontin (opn) (200 ug) |
200 ug |
r&d systems |
441-op-200/cf |
recombinant mouse osteopontin (opn), cf (200 ug) |
200 ug |
r&d systems |
442-lk-002 |
recombinant mouse cxcl15/lungkine (2 ug) |
2 ug |
r&d systems |
4434-ck-025 |
recombinant rat ccl27/ctack |
25 µg |
r&d systems |
4434-ck-025/cf |
recombinant rat ccl27/ctack, cf |
25 µg |
r&d systems |
4435-bd-050 |
recombinant human beta-defensin 3, cf |
50 µg |
r&d systems |
4436-dn-050 |
recombinant mouse dnam-1/fc chimera, cf |
50 µg |
r&d systems |
4437-il-025 |
recombinant rat il-17f |
25 µg |
r&d systems |
4437-il-025 |
recombinant rat il-17f |
25 µg |
r&d systems |
4437-il-025/cf |
recombinant rat il-17f, cf |
25 µg |
r&d systems |
4437-il-025/cf |
recombinant rat il-17f, cf |
25 µg |
r&d systems |
443-kd-050 |
recombinant mouse vegf r2/flk-1/fc chimera (50 ug) |
50 ug |
r&d systems |
443-kd-050/cf |
recombinant mouse vegf r2/flk-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
4444-tr-050 |
recombinant human thrombopoietin r, cf |
50 µg |
r&d systems |
444-bns-100 |
recombinant mouse bmpr-ib/alk-6/fc chimera (nso) (100 ug) |
100 ug |
r&d systems |
444-bns-100/cf |
recombinant mouse bmpr-ib/alk-6/fc chimera (nso), cf (100 ug) |
100 ug |
r&d systems |
4460-mg-100 |
recombinant mouse igg2a fc, cf |
100 µg |
r&d systems |
446-b4-200 |
recombinant mouse ephb4/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
447-ml-010 |
recombinant mouse il-15 (10 ug) |
10 ug |
r&d systems |
447-ml-010/cf |
recombinant mouse il-15, cf (10 ug) |
10 ug |
r&d systems |
4480-lr-050 |
recombinant mouse lrpap, cf |
50 µg |
r&d systems |
4481-mr-100 |
recombinant mouse il-17 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
4484-n2-050 |
recombinant human neuregulin-2/nrg2, cf |
50 µg |
r&d systems |
4485-nx-050 |
recombinant rat neurexin 1 alpha/nrxn1a, cf |
50 µg |
r&d systems |
4486-sb-050 |
recombinant human sirp gamma/cd172g/fc chimera, cf |
50 µg |
r&d systems |
4487-an-050 |
recombinant human angiopoietin-like 4, cf |
50 µg |
r&d systems |
4488-en-010 |
recombinant mouse 5'-nucleotidase/cd73, cf |
10 µg |
r&d systems |
4490-hp-050 |
recombinant human hemopexin, cf |
50 µg |
r&d systems |
4494-ah-010 |
recombinant human asahl, cf |
10 µg |
r&d systems |
450-ma-010 |
recombinant mouse ccl3/mip-1 alpha (10 ug) |
10 ug |
r&d systems |
450-ma-010/cf |
recombinant mouse ccl3/mip-1 alpha, cf (10 ug) |
10 ug |
r&d systems |
450-ma-050 |
recombinant mouse ccl3/mip-1 alpha (50 ug) |
50 ug |
r&d systems |
450-ma-050/cf |
recombinant mouse ccl3/mip-1 alpha, cf (50 ug) |
50 ug |
r&d systems |
4516-zn-010 |
recombinant rat ace-2, cf |
10 µg |
r&d systems |
4517-se-010 |
recombinant mouse neutrophil elastase/ela2, cf |
10 µg |
r&d systems |
4518-rb-050 |
recombinant mouse erbb3/fc chimera, cf |
50 µg |
r&d systems |
451-mb-010 |
recombinant mouse ccl4/mip-1 beta (10 ug) |
10 ug |
r&d systems |
451-mb-010/cf |
recombinant mouse ccl4/mip-1 beta, cf (10 ug) |
10 ug |
r&d systems |
451-mb-050 |
recombinant mouse ccl4/mip-1 beta (50 ug) |
50 ug |
r&d systems |
451-mb-050/cf |
recombinant mouse ccl4/mip-1 beta, cf (50 ug) |
50 ug |
r&d systems |
4520-gp-050 |
recombinant mouse glypican 1, cf |
50 µg |
r&d systems |
4529-hb-050 |
recombinant mouse habp1/c1qbp, cf |
50 µg |
r&d systems |
452-m2-010 |
recombinant mouse mip-2 (10 ug) |
10 ug |
r&d systems |
452-m2-010/cf |
recombinant mouse mip-2, cf (10 ug) |
10 ug |
r&d systems |
452-m2-050 |
recombinant mouse mip-2 (50 ug) |
50 ug |
r&d systems |
452-m2-050/cf |
recombinant mouse mip-2, cf (50 ug) |
50 ug |
r&d systems |
453-kc-010 |
recombinant mouse kc (10 ug) |
10 ug |
r&d systems |
453-kc-010/cf |
recombinant mouse kc, cf (10 ug) |
10 ug |
r&d systems |
453-kc-050 |
recombinant mouse kc (50 ug) |
50 ug |
r&d systems |
453-kc-050/cf |
recombinant mouse kc, cf (50 ug) |
50 ug |
r&d systems |
4540-ks-010 |
recombinant human active raf-1 (y340e y341e, 306-end), cf |
10 µg |
r&d systems |
4544-ns-050 |
recombinant human insl3, cf |
50 µg |
r&d systems |
4546-sa-050 |
recombinant human sirp alpha/cd172a, cf |
50 µg |
r&d systems |
454-a8-200 |
recombinant mouse epha8/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
4556-se-010 |
recombinant mouse coagulation factor xi, cf |
10 µg |
r&d systems |
4557-pi-010 |
recombinant mouse cystatin f, cf |
10 µg |
r&d systems |
455-mc-010 |
recombinant mouse scf (10 ug) |
10 ug |
r&d systems |
455-mc-010/cf |
recombinant mouse scf, cf (10 ug) |
10 ug |
r&d systems |
455-mc-050 |
recombinant mouse scf (50 ug) |
50 ug |
r&d systems |
455-mc-050/cf |
recombinant mouse scf, cf (50 ug) |
50 ug |
r&d systems |
456-mc-010 |
recombinant mouse ccl7/marc (10 ug) |
10 ug |
r&d systems |
456-mc-010/cf |
recombinant mouse ccl7/marc, cf (10 ug) |
10 ug |
r&d systems |
456-mc-050 |
recombinant mouse ccl7/marc (50 ug) |
50 ug |
r&d systems |
456-mc-050/cf |
recombinant mouse ccl7/marc, cf (50 ug) |
50 ug |
r&d systems |
457-6c-025 |
recombinant mouse ccl21/6ckine (25 ug) |
25 ug |
r&d systems |
457-6c-025/cf |
recombinant mouse ccl21/6ckine, cf (25 ug) |
25 ug |
r&d systems |
458-mf-025 |
recombinant mouse cx3cl1/fractalkine (chemokine domain) (25 ug) |
25 ug |
r&d systems |
458-mf-025/cf |
recombinant mouse cx3cl1/fractalkine (chemokine domain), cf (25 ug) |
25 ug |
r&d systems |
459-mo-100 |
recombinant mouse osteoprotegerin/tnfrsf11b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
4600-su-010 |
recombinant mouse arylsulfatase g/arsg, cf |
10 µg |
r&d systems |
4604-tg-050 |
recombinant human transglutaminase 3/tgm3, cf |
50 µg |
r&d systems |
460-sd-010 |
recombinant mouse cxcl12/sdf-1 alpha (10 ug) |
10 ug |
r&d systems |
460-sd-010/cf |
recombinant mouse cxcl12/sdf-1 alpha, cf (10 ug) |
10 ug |
r&d systems |
460-sd-050 |
recombinant mouse cxcl12/sdf-1 alpha (50 ug) |
50 ug |
r&d systems |
460-sd-050/cf |
recombinant mouse cxcl12/sdf-1 alpha, cf (50 ug) |
50 ug |
r&d systems |
4610-th-010 |
recombinant human tsh alpha/beta |
10 µg |
r&d systems |
461-sh-025 |
recombinant mouse sonic hedgehog, n-terminus (shh-n) (25 ug) |
25 ug |
r&d systems |
461-sh-025/cf |
recombinant mouse sonic hedgehog, n-terminus (shh-n), cf (25 ug) |
25 ug |
r&d systems |
4628-sf-050 |
recombinant mouse cracc/slamf7, cf |
50 µg |
r&d systems |
4629-dp-050 |
recombinant human dermatopontin, cf |
50 µg |
r&d systems |
462-tec-010 |
recombinant mouse trance/rank l/tnfsf11 (e. coli-expressed) (10 ug) |
10 ug |
r&d systems |
462-tec-010/cf |
recombinant mouse trance/rank l/tnfsf11 (e. coli), cf (10 ug) |
10 ug |
r&d systems |
462-tr-010 |
recombinant mouse trance/rank l/tnfsf11 (10 ug) |
10 ug |
r&d systems |
462-tr-010/cf |
recombinant mouse trance/rank l/tnfsf11, cf (10 ug) |
10 ug |
r&d systems |
4630-dc-050 |
recombinant human desmocollin-3, cf |
50 µg |
r&d systems |
4635-ml-025 |
recombinant mouse il-28a/ifn-lambda 2 |
25 µg |
r&d systems |
4635-ml-025/cf |
recombinant mouse il-28a/ifn-lambda 2, cf |
25 µg |
r&d systems |
4636-nl-050 |
recombinant mouse noelin-1, cf |
50 µg |
r&d systems |
463-mg-025 |
recombinant mouse ccl9/10/mip-1 gamma (25 ug) |
25 ug |
r&d systems |
463-mg-025/cf |
recombinant mouse ccl9/10/mip-1 gamma, cf (25 ug) |
25 ug |
r&d systems |
4644-vs-010 |
recombinant human vegf 121 (aa 207-327) |
10 µg |
r&d systems |
4644-vs-010/cf |
recombinant human vegf 121 (aa 207-327) |
10 µg |
r&d systems |
464-sh-025 |
recombinant mouse sonic hedgehog (c25ii) n-terminus (25 ug) |
25 ug |
r&d systems |
464-sh-025/cf |
recombinant mouse sonic hedgehog (c25ii) n-terminus, cf (25 ug) |
25 ug |
r&d systems |
465-pl-010 |
recombinant mouse plgf-2 (10 ug) |
10 ug |
r&d systems |
465-pl-010/cf |
recombinant mouse plgf-2, cf (10 ug) |
10 ug |
r&d systems |
465-pl-050 |
recombinant mouse plgf-2 (50 ug) |
50 ug |
r&d systems |
465-pl-050/cf |
recombinant mouse plgf-2, cf (50 ug) |
50 ug |
r&d systems |
466-cr-010 |
recombinant mouse cxcl10/ip-10/crg-2 (10 ug) |
10 ug |
r&d systems |
466-cr-010/cf |
recombinant mouse cxcl10/ip-10/crg-2, cf (10 ug) |
10 ug |
r&d systems |
466-cr-050 |
recombinant mouse cxcl10/ip-10/crg-2 (50 ug) |
50 ug |
r&d systems |
466-cr-050/cf |
recombinant mouse cxcl10/ip-10/crg-2, cf (50 ug) |
50 ug |
r&d systems |
467-b2-200 |
recombinant mouse ephb2/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
4687-cl-050 |
recombinant mouse cl-k1/colec11, cf |
50 µg |
r&d systems |
468-mg-100 |
recombinant mouse gp130/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
4694-s4-050 |
recombinant human semaphorin 4a/fc chimera, cf |
50 µg |
r&d systems |
469-vd-025 |
recombinant mouse vegf-d (25 ug) |
25 ug |
r&d systems |
469-vd-025/cf |
recombinant mouse vegf-d, cf (25 ug) |
25 ug |
r&d systems |
470-bc-025 |
recombinant mouse cxcl13/blc/bca-1 (25 ug) |
25 ug |
r&d systems |
470-bc-025/cf |
recombinant mouse cxcl13/blc/bca-1, cf (25 ug) |
25 ug |
r&d systems |
4710-ac-050 |
recombinant mouse cd157, cf |
50 µg |
r&d systems |
4714-zn-020 |
recombinant human methionine aminopeptidase 1d, cf |
20 µg |
r&d systems |
471-f1-100 |
recombinant mouse vegf r1/flt-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
472-ff-025 |
recombinant mouse cx3cl1/fractalkine (full length) (25 ug) |
25 ug |
r&d systems |
472-ff-025/cf |
recombinant mouse cx3cl1/fractalkine (full length), cf (25 ug) |
25 ug |
r&d systems |
4736-ac-050 |
recombinant human cd157, cf |
50 µg |
r&d systems |
473-eb-200 |
recombinant mouse ephrin-b1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
4749-mr-050 |
recombinant human mis rii/fc chimera, cf |
50 µg |
r&d systems |
474-mr-025 |
recombinant mouse il-10 sr alpha (25 ug) |
25 ug |
r&d systems |
474-mr-025/cf |
recombinant mouse il-10 sr alpha, cf (25 ug) |
25 ug |
r&d systems |
4750-rg-050 |
recombinant canine rage, cf |
50 µg |
r&d systems |
4754-sr-050 |
recombinant mouse scara5, cf |
50 µg |
r&d systems |
4778-cr-010 |
recombinant variola crmb |
10 µg |
r&d systems |
4778-cr-010/cf |
recombinant variola crmb, cf |
10 µg |
r&d systems |
477-mn-025 |
recombinant mouse neurturin (25 ug) |
25 ug |
r&d systems |
477-mn-025/cf |
recombinant mouse neurturin, cf (25 ug) |
25 ug |
r&d systems |
478-mr-025 |
recombinant mouse ccl5/rantes (25 ug) |
25 ug |
r&d systems |
478-mr-025/cf |
recombinant mouse ccl5/rantes, cf (25 ug) |
25 ug |
r&d systems |
479-je-010 |
recombinant mouse ccl2/je/mcp-1 (10 ug) |
10 ug |
r&d systems |
479-je-010/cf |
recombinant mouse ccl2/je/mcp-1, cf (10 ug) |
10 ug |
r&d systems |
479-je-050 |
recombinant mouse ccl2/je/mcp-1 (50 ug) |
50 ug |
r&d systems |
479-je-050/cf |
recombinant mouse ccl2/je/mcp-1, cf (50 ug) |
50 ug |
r&d systems |
480-rm-010 |
recombinant mouse il-1ra/il-1f3 (10 ug) |
10 ug |
r&d systems |
480-rm-010/cf |
recombinant mouse il-1ra/il-1f3, cf (10 ug) |
10 ug |
r&d systems |
480-rm-050 |
recombinant mouse il-1ra/il-1f3 (50 ug) |
50 ug |
r&d systems |
480-rm-050/cf |
recombinant mouse il-1ra/il-1f3, cf (50 ug) |
50 ug |
r&d systems |
481-tk-025 |
recombinant mouse ccl25/teck (25 ug) |
25 ug |
r&d systems |
481-tk-025/cf |
recombinant mouse ccl25/teck, cf (25 ug) |
25 ug |
r&d systems |
482-rt-100 |
recombinant mouse ret/fc chimera (100 ug) |
100 ug |
r&d systems |
482-rt-100/cf |
recombinant mouse ret/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
483-cd-200 |
recombinant mouse cd28/fc chimera (200 ug) |
200 ug |
r&d systems |
483-cd-200/cf |
recombinant mouse cd28/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
485-mi-100/cf |
recombinant mouse ifn-gamma, cf (100 ug) |
100 ug |
r&d systems |
486-lt-025 |
recombinant mouse xcl1/lymphotactin (25 ug) |
25 ug |
r&d systems |
486-lt-025/cf |
recombinant mouse xcl1/lymphotactin, cf (25 ug) |
25 ug |
r&d systems |
487-c-010 |
recombinant mouse ccl6/c10 (10 ug) |
10 ug |
r&d systems |
487-c-010/cf |
recombinant mouse ccl6/c10, cf (10 ug) |
10 ug |
r&d systems |
487-c-050 |
recombinant mouse ccl6/c10 (50 ug) |
50 ug |
r&d systems |
487-c-050/cf |
recombinant mouse ccl6/c10, cf (50 ug) |
50 ug |
r&d systems |
488-to-005 |
recombinant mouse thrombopoietin (5 ug) |
5 ug |
r&d systems |
488-to-005/cf |
recombinant mouse thrombopoietin, cf (5 ug) |
5 ug |
r&d systems |
488-to-025 |
recombinant mouse thrombopoietin (25 ug) |
25 ug |
r&d systems |
488-to-025/cf |
recombinant mouse thrombopoietin, cf (25 ug) |
25 ug |
r&d systems |
4891-025-k |
tacs xtt cell proliferation/viability assay |
2500 tests |
r&d systems |
4891-025-k |
tacs xtt cell proliferation/viability assay |
2500 tests |
r&d systems |
4892-010-k |
calcein am cell viability assay |
1000 tests |
r&d systems |
4892-010-k |
calcein am cell viability assay |
1000 tests |
r&d systems |
490-ir-200 |
recombinant mouse il-11 ra/fc chimera (200 ug) |
200 ug |
r&d systems |
490-ir-200/cf |
recombinant mouse il-11 ra/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
491-ir-200 |
recombinant mouse il-13 r alpha 1/fc chimera (200 ug) |
200 ug |
r&d systems |
491-ir-200/cf |
recombinant mouse il-13 r alpha 1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
492-mm-010 |
recombinant mouse cxcl9/mig (10 ug) |
10 ug |
r&d systems |
492-mm-010/cf |
recombinant mouse cxcl9/mig, cf (10 ug) |
10 ug |
r&d systems |
492-mm-050 |
recombinant mouse cxcl9/mig (50 ug) |
50 ug |
r&d systems |
492-mm-050/cf |
recombinant mouse cxcl9/mig, cf (50 ug) |
50 ug |
r&d systems |
493-mv-005 |
recombinant mouse vegf 164 (5 ug) |
5 ug |
r&d systems |
493-mv-005/cf |
recombinant mouse vegf 164, cf (5 ug) |
5 ug |
r&d systems |
493-mv-025 |
recombinant mouse vegf 164 (25 ug) |
25 ug |
r&d systems |
493-mv-025/cf |
recombinant mouse vegf 164, cf (25 ug) |
25 ug |
r&d systems |
494-ve-005 |
recombinant mouse vegf 120 (5 ug) |
5 ug |
r&d systems |
494-ve-005/cf |
recombinant mouse vegf 120, cf (5 ug) |
5 ug |
r&d systems |
494-ve-025 |
recombinant mouse vegf 120 (25 ug) |
25 ug |
r&d systems |
494-ve-025/cf |
recombinant mouse vegf 120, cf (25 ug) |
25 ug |
r&d systems |
495-mo-025 |
recombinant mouse oncostatin m (osm) (25 ug) |
25 ug |
r&d systems |
495-mo-025/cf |
recombinant mouse oncostatin m (osm), cf (25 ug) |
25 ug |
r&d systems |
496-eb-200 |
recombinant mouse ephrin-b2/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
497-lr-100 |
recombinant mouse leptin r/fc chimera (100 ug) |
100 ug |
r&d systems |
497-lr-100/cf |
recombinant mouse leptin r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
498-ob-01m |
recombinant mouse leptin, cf (1 mg) |
1 mg |
r&d systems |
498-ob-05m |
recombinant mouse leptin, cf (5 mg) |
5 mg |
r&d systems |
499-ml-025 |
recombinant mouse il-12/il-23 p40 homodimer (25 ug) |
25 ug |
r&d systems |
499-ml-025/cf |
recombinant mouse il-12/il-23 p40 homodimer, cf (25 ug) |
25 ug |
r&d systems |
5-001-a |
normal sheep igg control (1 mg) |
1 mg |
r&d systems |
500-rl-005 |
recombinant rat il-1 alpha/il-1f1 (5 ug) |
5 ug |
r&d systems |
500-rl-005/cf |
recombinant rat il-1 alpha/il-1f1, cf (5 ug) |
5 ug |
r&d systems |
500-rl-025 |
recombinant rat il-1 alpha/il-1f1 (25 ug) |
25 ug |
r&d systems |
500-rl-025/cf |
recombinant rat il-1 alpha/il-1f1, cf (25 ug) |
25 ug |
r&d systems |
501-rl-010 |
recombinant rat il-1 beta/il-1f2 (10 ug) |
10 ug |
r&d systems |
501-rl-010/cf |
recombinant rat il-1 beta/il-1f2, cf (10 ug) |
10 ug |
r&d systems |
501-rl-050 |
recombinant rat il-1 beta/il-1f2 (50 ug) |
50 ug |
r&d systems |
501-rl-050/cf |
recombinant rat il-1 beta/il-1f2, cf (50 ug) |
50 ug |
r&d systems |
502-rl-010 |
recombinant rat il-2 (10 ug) |
10 ug |
r&d systems |
502-rl-010/cf |
recombinant rat il-2, cf (10 ug) |
10 ug |
r&d systems |
502-rl-050 |
recombinant rat il-2 (50 ug) |
50 ug |
r&d systems |
502-rl-050/cf |
recombinant rat il-2, cf (50 ug) |
50 ug |
r&d systems |
503-cx-025 |
recombinant mouse cxcl16 (25 ug) |
25 ug |
r&d systems |
503-cx-025/cf |
recombinant mouse cxcl16, cf (25 ug) |
25 ug |
r&d systems |
504-rl-005 |
recombinant rat il-4 (5 ug) |
5 ug |
r&d systems |
504-rl-005/cf |
recombinant rat il-4, cf (5 ug) |
5 ug |
r&d systems |
504-rl-025 |
recombinant rat il-4 (25 ug) |
25 ug |
r&d systems |
504-rl-025/cf |
recombinant rat il-4, cf (25 ug) |
25 ug |
r&d systems |
505-pr-100 |
recombinant human bmpr-ib/alk-6/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
506-rl-010 |
recombinant rat il-6 (10 ug) |
10 ug |
r&d systems |
506-rl-010/cf |
recombinant rat il-6, cf (10 ug) |
10 ug |
r&d systems |
506-rl-050 |
recombinant rat il-6 (50 ug) |
50 ug |
r&d systems |
506-rl-050/cf |
recombinant rat il-6, cf (50 ug) |
50 ug |
r&d systems |
507-bp-020 |
recombinant human bmp-6 (20 ug) |
20 ug |
r&d systems |
507-bp-020/cf |
recombinant human bmp-6, cf (20 ug) |
20 ug |
r&d systems |
508-ck-025 |
recombinant human ccl23/ck beta 8-1 (aa 46-137) (25 ug) |
25 ug |
r&d systems |
508-ck-025/cf |
recombinant human ccl23/ck beta 8-1 (aa 46-137), cf (25 ug) |
25 ug |
r&d systems |
509-mi-025 |
recombinant human ccl3l1/mip-1 alpha isoform ld78 beta (25 ug) |
25 ug |
r&d systems |
509-mi-025/cf |
recombinant human ccl3l1/mip-1 alpha isoform ld78 beta, cf (25 ug) |
25 ug |
r&d systems |
510-rt-010 |
recombinant rat tnf-alpha/tnfsf1a (10 ug) |
10 ug |
r&d systems |
510-rt-010/cf |
recombinant rat tnf-alpha/tnfsf2, cf (10 ug) |
10 ug |
r&d systems |
510-rt-050 |
recombinant rat tnf-alpha/tnfsf1a (50 ug) |
50 ug |
r&d systems |
510-rt-050/cf |
recombinant rat tnf-alpha/tnfsf2, cf (50 ug) |
50 ug |
r&d systems |
511-mm-010 |
recombinant human mmp-13, cf (10 ug) |
10 ug |
r&d systems |
512-gf-010 |
recombinant rat gdnf (10 ug) |
10 ug |
r&d systems |
512-gf-010/cf |
recombinant rat gdnf, cf (10 ug) |
10 ug |
r&d systems |
512-gf-050 |
recombinant rat gdnf (50 ug) |
50 ug |
r&d systems |
512-gf-050/cf |
recombinant rat gdnf, cf (50 ug) |
50 ug |
r&d systems |
513-mp-010 |
recombinant human mmp-3, cf (10 ug) |
10 ug |
r&d systems |
514-cd-050 |
recombinant human scd4 (50 ug) |
50 ug |
r&d systems |
514-cd-050/cf |
recombinant human scd4, cf (50 ug) |
50 ug |
r&d systems |
515-cn-010 |
recombinant rat cinc-1 (10 ug) |
10 ug |
r&d systems |
515-cn-010/cf |
recombinant rat cinc-1, cf (10 ug) |
10 ug |
r&d systems |
515-cn-050 |
recombinant rat cinc-1 (50 ug) |
50 ug |
r&d systems |
515-cn-050/cf |
recombinant rat cinc-1, cf (50 ug) |
50 ug |
r&d systems |
516-ca-025 |
recombinant rat cinc-2 alpha (25 ug) |
25 ug |
r&d systems |
516-ca-025/cf |
recombinant rat cinc-2 alpha, cf (25 ug) |
25 ug |
r&d systems |
517-cb-025 |
recombinant rat cinc-2 beta (25 ug) |
25 ug |
r&d systems |
517-cb-025/cf |
recombinant rat cinc-2 beta, cf (25 ug) |
25 ug |
r&d systems |
518-gm-005 |
recombinant rat gm-csf (5 ug) |
5 ug |
r&d systems |
518-gm-005/cf |
recombinant rat gm-csf, cf (5 ug) |
5 ug |
r&d systems |
518-gm-025 |
recombinant rat gm-csf (25 ug) |
25 ug |
r&d systems |
518-gm-025/cf |
recombinant rat gm-csf, cf (25 ug) |
25 ug |
r&d systems |
520-bb-050 |
recombinant rat pdgf-bb (50 ug) |
50 ug |
r&d systems |
520-bb-050/cf |
recombinant rat pdgf-bb, cf (50 ug) |
50 ug |
r&d systems |
521-rl-025 |
recombinant rat il-18/il-1f4 (25 ug) |
25 ug |
r&d systems |
521-rl-025/cf |
recombinant rat il-18/il-1f4, cf (25 ug) |
25 ug |
r&d systems |
522-rl-005 |
recombinant rat il-10 (5 ug) |
5 ug |
r&d systems |
522-rl-005/cf |
recombinant rat il-10, cf (5 ug) |
5 ug |
r&d systems |
522-rl-025 |
recombinant rat il-10 (25 ug) |
25 ug |
r&d systems |
522-rl-025/cf |
recombinant rat il-10, cf (25 ug) |
25 ug |
r&d systems |
523-st-100 |
recombinant human il-1 r4/st2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
524-gr-050 |
recombinant mouse gitr/tnfrsf18/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
525-c3-025 |
recombinant rat cinc-3 (25 ug) |
25 ug |
r&d systems |
525-c3-025/cf |
recombinant rat cinc-3, cf (25 ug) |
25 ug |
r&d systems |
526-sa-050 |
recombinant mouse fas ligand/tnfsf6 (50 ug) |
50 ug |
r&d systems |
526-sa-050/cf |
recombinant mouse fas ligand/tnfsf6, cf (50 ug) |
50 ug |
r&d systems |
527-me-100 |
recombinant mouse hgf r/c-met/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
528-mp-025 |
recombinant mouse ccl24/eotaxin-2/mpif-2 (25 ug) |
25 ug |
r&d systems |
528-mp-025/cf |
recombinant mouse ccl24/eotaxin-2/mpif-2, cf (25 ug) |
25 ug |
r&d systems |
529-tr-025 |
recombinant mouse ccl17/tarc (25 ug) |
25 ug |
r&d systems |
529-tr-025/cf |
recombinant mouse ccl17/tarc, cf (25 ug) |
25 ug |
r&d systems |
530-mr-100 |
recombinant mouse il-4 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
531-pa-100 |
recombinant mouse upar/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
532-r2-050 |
recombinant mouse tgf-beta rii(human)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
533-vi-025 |
recombinant mouse ccl28 (25 ug) |
25 ug |
r&d systems |
533-vi-025/cf |
recombinant mouse ccl28, cf (25 ug) |
25 ug |
r&d systems |
535-in-025 |
recombinant porcine cxcl8/il-8 (25 ug) |
25 ug |
r&d systems |
535-in-025/cf |
recombinant porcine cxcl8/il-8, cf (25 ug) |
25 ug |
r&d systems |
536-fr-025 |
recombinant rat cx3cl1/fractalkine (25 ug) |
25 ug |
r&d systems |
536-fr-025/cf |
recombinant rat cx3cl1/fractalkine, cf (25 ug) |
25 ug |
r&d systems |
537-ft-025 |
recombinant rat cx3cl1/fractalkine (chemokine domain) (25 ug) |
25 ug |
r&d systems |
537-ft-025/cf |
recombinant rat cx3cl1/fractalkine (chemokine domain), cf (25 ug) |
25 ug |
r&d systems |
539-ir-100 |
recombinant mouse il-13 r alpha 2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
540-rm-025 |
recombinant rat ccl20/mip-3 alpha (25 ug) |
25 ug |
r&d systems |
540-rm-025/cf |
recombinant rat ccl20/mip-3 alpha, cf (25 ug) |
25 ug |
r&d systems |
541-a5-200 |
recombinant rat epha5/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
543-rl-025 |
recombinant rat lix (25 ug) |
25 ug |
r&d systems |
543-rl-025/cf |
recombinant rat lix, cf (25 ug) |
25 ug |
r&d systems |
545-rl-010 |
recombinant rat il-5 (10 ug) |
10 ug |
r&d systems |
545-rl-010/cf |
recombinant rat il-5, cf (10 ug) |
10 ug |
r&d systems |
546-tr-050 |
recombinant mouse tslp r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
547-rl-010 |
recombinant rat il-10 (cys 167 tyr) (10 ug) |
10 ug |
r&d systems |
547-rl-010/cf |
recombinant rat il-10 (cys 167 tyr), cf (10 ug) |
10 ug |
r&d systems |
548-mm-010 |
recombinant mouse mmp-3, cf (10 ug) |
10 ug |
r&d systems |
549-r3-100 |
recombinant mouse il-3 r beta/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
550-ag-100 |
recombinant rat agrin (100 ug) |
100 ug |
r&d systems |
550-ag-100/cf |
recombinant rat agrin, cf (100 ug) |
100 ug |
r&d systems |
551-mr-100 |
recombinant mouse il-15 r alpha/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
552-r1-010 |
recombinant cotton rat il-1 alpha/il-1f1 (10 ug) |
10 ug |
r&d systems |
552-r1-010/cf |
recombinant cotton rat il-1 alpha/il-1f1, cf (10 ug) |
10 ug |
r&d systems |
555-ts-010 |
recombinant mouse tslp (10 ug) |
10 ug |
r&d systems |
555-ts-010/cf |
recombinant mouse tslp, cf (10 ug) |
10 ug |
r&d systems |
556-ng-100 |
recombinant rat beta-ngf (100 ug) |
100 ug |
r&d systems |
556-ng-100/cf |
recombinant rat beta-ngf, cf (100 ug) |
100 ug |
r&d systems |
557-nt-010 |
recombinant rat cntf (10 ug) |
10 ug |
r&d systems |
557-nt-010/cf |
recombinant rat cntf, cf (10 ug) |
10 ug |
r&d systems |
557-nt-050 |
recombinant rat cntf (50 ug) |
50 ug |
r&d systems |
557-nt-050/cf |
recombinant rat cntf, cf (50 ug) |
50 ug |
r&d systems |
558-cr-050 |
recombinant rat cntf sr alpha (50 ug) |
50 ug |
r&d systems |
558-cr-050/cf |
recombinant rat cntf sr alpha, cf (50 ug) |
50 ug |
r&d systems |
560-gr-100/cf |
recombinant rat gfr alpha-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
561-r6-025 |
recombinant cotton rat il-6 (25 ug) |
25 ug |
r&d systems |
561-r6-025/cf |
recombinant cotton rat il-6, cf (25 ug) |
25 ug |
r&d systems |
563-mr-100 |
recombinant mouse il-1 rii/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
564-rv-010 |
recombinant rat vegf 164 (10 ug) |
10 ug |
r&d systems |
564-rv-010/cf |
recombinant rat vegf 164, cf (10 ug) |
10 ug |
r&d systems |
564-rv-050 |
recombinant rat vegf 164 (50 ug) |
50 ug |
r&d systems |
564-rv-050/cf |
recombinant rat vegf 164, cf (50 ug) |
50 ug |
r&d systems |
565-rg-025 |
recombinant cotton rat ifn-gamma (25 ug) |
25 ug |
r&d systems |
565-rg-025/cf |
recombinant cotton rat ifn-gamma, cf (25 ug) |
25 ug |
r&d systems |
566-n1-025 |
recombinant rat neuropilin-1/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
566-nns-025 |
recombinant rat neuropilin-1/fc chimera (nso-expressed), cf (25 ug) |
25 ug |
r&d systems |
567-n2-025 |
recombinant rat neuropilin-2/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
568-fr-025 |
recombinant rat cx3cl1/fractalkine (aa 22100) (25 ug) |
25 ug |
r&d systems |
568-fr-025/cf |
recombinant rat cx3cl1/fractalkine (aa 22100), cf (25 ug) |
25 ug |
r&d systems |
569-a4-200 |
recombinant mouse ephrin-a4/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
571-mf-025 |
recombinant mouse cx3cl1/fractalkine (aa 25-105) (25 ug) |
25 ug |
r&d systems |
571-mf-025/cf |
recombinant mouse cx3cl1/fractalkine (aa 25-105), cf (25 ug) |
25 ug |
r&d systems |
572-mc-025 |
recombinant mouse cxcl11/i-tac (25 ug) |
25 ug |
r&d systems |
572-mc-025/cf |
recombinant mouse cxcl11/i-tac, cf (25 ug) |
25 ug |
r&d systems |
573-rp-100 |
recombinant rat il-1 r6/il-1 r rp2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
574-cd-050 |
recombinant mouse cd27/tnfrsf7/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
575-es-100 |
recombinant mouse e-selectin (cd62e)/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
576-ls-100 |
recombinant mouse l-selectin/cd62l/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
577-a7-100 |
recombinant rat alk-7/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
578-b5-025 |
recombinant mouse igfbp-5, cf (25 ug) |
25 ug |
r&d systems |
579-r2-020 |
recombinant cotton rat il-2 (20 ug) |
20 ug |
r&d systems |
579-r2-020/cf |
recombinant cotton rat il-2, cf (20 ug) |
20 ug |
r&d systems |
580-rt-010 |
recombinant rat timp-1, cf (10 ug) |
10 ug |
r&d systems |
581-cr-010 |
recombinant cotton rat il-10 (cys 149 tyr) (10 ug) |
10 ug |
r&d systems |
581-cr-010/cf |
recombinant cotton rat il-10 (tyr), cf (10 ug) |
10 ug |
r&d systems |
582-ml-010 |
recombinant mouse il-22 (10 ug) |
10 ug |
r&d systems |
582-ml-010/cf |
recombinant mouse il-22, cf (10 ug) |
10 ug |
r&d systems |
583-ic-050 |
recombinant rat icam-1/cd54/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
584-r4-010 |
recombinant cotton rat il-4 (10 ug) |
10 ug |
r&d systems |
584-r4-010/cf |
recombinant cotton rat il-4, cf (10 ug) |
10 ug |
r&d systems |
585-if-100 |
recombinant rat ifn-gamma (100 ug) |
100 ug |
r&d systems |
585-if-100/cf |
recombinant rat ifn-gamma, cf (100 ug) |
100 ug |
r&d systems |
587-ri-050 |
recombinant mouse tgf-beta ri/alk-5/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
588-pl-025 |
recombinant porcine il-18/il-1f4 (25 ug) |
25 ug |
r&d systems |
588-pl-025/cf |
recombinant porcine il-18/il-1f4, cf (25 ug) |
25 ug |
r&d systems |
591-mr-100 |
recombinant mouse mer/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
592-fr-010 |
recombinant mouse sfrp-3 (10 ug) |
10 ug |
r&d systems |
592-fr-010/cf |
recombinant mouse sfrp-3, cf (10 ug) |
10 ug |
r&d systems |
593-bc-050 |
recombinant mouse bcma/tnfrsf17/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
594-ml-010 |
recombinant mouse il-21 (10 ug) |
10 ug |
r&d systems |
594-ml-010/cf |
recombinant mouse il-21, cf (10 ug) |
10 ug |
r&d systems |
595-p4-025 |
recombinant mouse cxcl4/pf4, cf (25 ug) |
25 ug |
r&d systems |
596-mr-100 |
recombinant mouse il-21 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
597-lm-010 |
recombinant mouse limitin/fc chimera, cf (10 ug) |
10 ug |
r&d systems |
598-lp-01m |
recombinant rat leptin, cf (1 mg) |
1 mg |
r&d systems |
598-lp-05m |
recombinant rat leptin, cf (5 mg) |
5 mg |
r&d systems |
599-jg-100 |
recombinant rat jagged 1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
6-001-a |
normal rat igg control (1 mg) |
1 mg |
r&d systems |
600-va-025 |
recombinant viral mip-i (25 ug) |
25 ug |
r&d systems |
600-va-025/cf |
recombinant viral mip-i, cf (25 ug) |
25 ug |
r&d systems |
601-vb-025 |
recombinant viral mip-ii (25 ug) |
25 ug |
r&d systems |
601-vb-025/cf |
recombinant viral mip-ii, cf (25 ug) |
25 ug |
r&d systems |
602-a1-200 |
recombinant mouse ephrin-a1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
603-a2-200 |
recombinant mouse ephrin-a2/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
604-4r-050 |
recombinant human il-4 r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
607-a6-200 |
recombinant mouse epha6/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
608-a7-200 |
recombinant mouse epha7/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
611-b6-200 |
recombinant mouse ephb6/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
612-cd-010 |
recombinant human cardiotrophin-1 (ct-1) (10 ug) |
10 ug |
r&d systems |
612-cd-010/cf |
recombinant human cardiotrophin-1 (ct-1), cf (10 ug) |
10 ug |
r&d systems |
612-cd-050 |
recombinant human cardiotrophin-1 (ct-1) (50 ug) |
50 ug |
r&d systems |
612-cd-050/cf |
recombinant human cardiotrophin-1 (ct-1), cf (50 ug) |
50 ug |
r&d systems |
613-fr-100 |
recombinant human gfr alpha-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
614-ins-100 |
recombinant human il-13 r alpha 2/fc chimera, (nso), cf (100 ug) |
100 ug |
r&d systems |
614-ir-100 |
recombinant human il-13 r alpha 2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
615-bm-050 |
recombinant human bmp-5 (50 ug) |
50 ug |
r&d systems |
615-bm-050/cf |
recombinant human bmp-5, cf (50 ug) |
50 ug |
r&d systems |
617-cl-050 |
recombinant human cd40 ligand/tnfsf5 (aa 108-261) (50 ug) |
50 ug |
r&d systems |
617-cl-050/cf |
recombinant human cd40 ligand/tnfsf5 (aa 108-261), cf (50 ug) |
50 ug |
r&d systems |
618-il-010 |
recombinant human cxcl8/il-8 (endothelial cell derived) (10 ug) |
10 ug |
r&d systems |
618-il-010/cf |
recombinant human cxcl8/il-8 (endothelial cell derived), cf (10 ug) |
10 ug |
r&d systems |
618-il-050 |
recombinant human cxcl8/il-8 (endothelial cell derived) (50 ug) |
50 ug |
r&d systems |
618-il-050/cf |
recombinant human cxcl8/il-8 (endothelial cell derived), cf (50 ug) |
50 ug |
r&d systems |
619-ti-100 |
recombinant human tie-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
620-cm-025 |
recombinant viral cmv ul146/vcxc1 (25 ug) |
25 ug |
r&d systems |
620-cm-025/cf |
recombinant viral cmv ul146/vcxc1, cf (25 ug) |
25 ug |
r&d systems |
622-vd-005 |
recombinant human vegf-d (5 ug) |
5 ug |
r&d systems |
622-vd-005/cf |
recombinant human vegf-d, cf (5 ug) |
5 ug |
r&d systems |
622-vd-025 |
recombinant human vegf-d (25 ug) |
25 ug |
r&d systems |
622-vd-025/cf |
recombinant human vegf-d, cf (25 ug) |
25 ug |
r&d systems |
623-an-025 |
recombinant human angiopoietin-2 (25 ug) |
25 ug |
r&d systems |
623-an-025/cf |
recombinant human angiopoietin-2, cf (25 ug) |
25 ug |
r&d systems |
627-cd-100 |
recombinant human cd6/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
628-lk-025 |
recombinant human ccl15/mip-1 delta/lkn-1 (68 aa) (25 ug) |
25 ug |
r&d systems |
628-lk-025/cf |
recombinant human ccl15/mip-1 delta/lkn-1 (68 aa), cf (25 ug) |
25 ug |
r&d systems |
629-lr-100 |
recombinant human lymphotoxin beta r (ltbr)/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
630-tr-100 |
recombinant human trail r3/tnfrsf10c/fc chimera (100 ug) |
100 ug |
r&d systems |
630-tr-100/cf |
recombinant human trail r3/tnfrsf10c/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
631-t2-100 |
recombinant human trail r2/tnfrsf10b/fc chimera (100 ug) |
100 ug |
r&d systems |
631-t2-100/cf |
recombinant human trail r2/tnfrsf10b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
633-tr-100 |
recombinant human trail r4/tnfrsf10d/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
634-ag-100 |
recombinant mouse agrp c-terminal fragment, cf |
100 µg |
r&d systems |
634-ag-100 |
recombinant mouse agrp c-terminal fragment, cf (100 ug) |
100 ug |
r&d systems |
635-ms-025 |
recombinant human msp beta chain (25 ug) |
25 ug |
r&d systems |
635-ms-025/cf |
recombinant human msp beta chain, cf (25 ug) |
25 ug |
r&d systems |
636-ag-100 |
recombinant mouse agrp c-terminal fragment, cf (100 ug) |
100 ug |
r&d systems |
636-r1-025 |
recombinant human stnf ri/tnfrsf1a (25 ug) |
25 ug |
r&d systems |
636-r1-025/cf |
recombinant human soluble tnf ri/tnfrsf1a, cf (25 ug) |
25 ug |
r&d systems |
637-ar-100 |
recombinant human activin ria/alk-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
638-a1-200 |
recombinant human epha1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
639-a2-200 |
recombinant mouse epha2/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
640-a3-200 |
recombinant mouse epha3/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
641-a4-200 |
recombinant mouse epha4/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
643-vm-050 |
recombinant mouse vcam-1/cd106/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
643-vm-200 |
recombinant mouse vcam-1/cd106/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
645-wn-010 |
recombinant mouse wnt-5a (10 ug) |
10 ug |
r&d systems |
645-wn-010/cf |
recombinant mouse wnt-5a, cf (10 ug) |
10 ug |
r&d systems |
648-ec-100 |
recombinant human e-cadherin/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
649-en-025 |
recombinant human cxcl5/ena-70 (25 ug) |
25 ug |
r&d systems |
649-en-025/cf |
recombinant human cxcl5/ena-70, cf (25 ug) |
25 ug |
r&d systems |
650-t2-100 |
recombinant human trop-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
651-na-025 |
recombinant human cxcl5/ena-74 (25 ug) |
25 ug |
r&d systems |
651-na-025/cf |
recombinant human cxcl5/ena-74, cf (25 ug) |
25 ug |
r&d systems |
652-p2-020 |
recombinant porcine il-2 (20 ug) |
20 ug |
r&d systems |
652-p2-020/cf |
recombinant porcine il-2, cf (20 ug) |
20 ug |
r&d systems |
653-e3-025 |
recombinant human ccl26/eotaxin-3 (25 ug) |
25 ug |
r&d systems |
653-e3-025/cf |
recombinant human ccl26/eotaxin-3, cf (25 ug) |
25 ug |
r&d systems |
654-p4-025 |
recombinant porcine il-4 (25 ug) |
25 ug |
r&d systems |
654-p4-025/cf |
recombinant porcine il-4, cf (25 ug) |
25 ug |
r&d systems |
655-fr-050 |
recombinant human fgf r1 alpha (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
656-al-100 |
recombinant human alcam/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
658-fr-050 |
recombinant human fgf r1 alpha (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
659-ab-005 |
recombinant human activin b (5 ug) |
5 ug |
r&d systems |
659-ab-005/cf |
recombinant human activin b, cf (5 ug) |
5 ug |
r&d systems |
659-ab-025 |
recombinant human activin b (25 ug) |
25 ug |
r&d systems |
659-ab-025/cf |
recombinant human activin b, cf (25 ug) |
25 ug |
r&d systems |
661-fr-050 |
recombinant human fgf r1 beta (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
662-or-100 |
recombinant mouse osm r beta/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
663-fr-050 |
recombinant human fgf r2 alpha (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
664-li-025 |
recombinant human light/tnfsf14 (25 ug) |
25 ug |
r&d systems |
664-li-025/cf |
recombinant human light/tnfsf14, cf (25 ug) |
25 ug |
r&d systems |
665-fr-050 |
recombinant human fgf r2 beta (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
666-dn-050 |
recombinant human dnam-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
669-fo-025 |
recombinant human follistatin (25 ug) |
25 ug |
r&d systems |
669-fo-025/cf |
recombinant human follistatin, cf (25 ug) |
25 ug |
r&d systems |
670-fr-100 |
recombinant human gfr alpha-3/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
671-gp-100 |
recombinant human gp130/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
672-it-025 |
recombinant human cxcl11/i-tac (25 ug) |
25 ug |
r&d systems |
672-it-025/cf |
recombinant human cxcl11/i-tac, cf (25 ug) |
25 ug |
r&d systems |
673-ir-100 |
recombinant human ifn-gamma r1 (100 ug) |
100 ug |
r&d systems |
673-ir-100/cf |
recombinant human ifn-gamma r1, cf (100 ug) |
100 ug |
r&d systems |
674-b2-025 |
recombinant human igfbp-2, cf (25 ug) |
25 ug |
r&d systems |
675-b3-025 |
recombinant human igfbp-3, cf (25 ug) |
25 ug |
r&d systems |
676-cp-100 |
recombinant human il-1 r3/il-1 r acp/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
678-ly-010 |
recombinant human lymphotoxin alpha1/beta2 (10 ug) |
10 ug |
r&d systems |
678-ly-010/cf |
recombinant human lymphotoxin alpha1/beta2, cf (10 ug) |
10 ug |
r&d systems |
679-tx-010 |
recombinant human lymphotoxin alpha2/beta1 (10 ug) |
10 ug |
r&d systems |
679-tx-010/cf |
recombinant human lymphotoxin alpha2/beta1, cf (10 ug) |
10 ug |
r&d systems |
680-pi-010 |
recombinant porcine il-1 alpha/il-1f1 (10 ug) |
10 ug |
r&d systems |
680-pi-010/cf |
recombinant porcine il-1 alpha/il-1f1, cf (10 ug) |
10 ug |
r&d systems |
681-pi-010 |
recombinant porcine il-1 beta/il-1f2 (10 ug) |
10 ug |
r&d systems |
681-pi-010/cf |
recombinant porcine il-1 beta/il-1f2, cf (10 ug) |
10 ug |
r&d systems |
682-pl-050 |
recombinant human prolactin, cf (50 ug) |
50 ug |
r&d systems |
683-rk-100 |
recombinant human rank/tnfrsf11a/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
684-fr-050 |
recombinant human fgf r2 beta (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
685-fr-050 |
recombinant human fgf r4/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
686-pi-025 |
recombinant porcine il-6 (25 ug) |
25 ug |
r&d systems |
686-pi-025/cf |
recombinant porcine il-6, cf (25 ug) |
25 ug |
r&d systems |
688-tk-100 |
recombinant human trkb/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
689-gr-100 |
recombinant human gitr/tnfrsf18/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
690-pt-025 |
recombinant porcine tnf-alpha/tnfsf1a (25 ug) |
25 ug |
r&d systems |
690-pt-025/cf |
recombinant porcine tnf-alpha/tnfsf2, cf (25 ug) |
25 ug |
r&d systems |
692-rk-100 |
recombinant mouse rank/tnfrsf11a/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
693-pi-010 |
recombinant porcine il-10 (10 ug) |
10 ug |
r&d systems |
693-pi-010/cf |
recombinant porcine il-10, cf (10 ug) |
10 ug |
r&d systems |
694-gl-025 |
recombinant human gitr ligand/tnfsf18 (25 ug) |
25 ug |
r&d systems |
r&d systems 产品目录列表 page 5 >> 1 2 3 4 5 6 7 8 9 10 >>..more |